2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | €18B | €18B | €29M | €22B | €23B |
Cost of Revenue | €0 | €0 | €0 | -€171M | €0 |
Gross Profit | €18B | €18B | €29M | €23B | €23B |
Gross Profit % | 100% | 100% | 100% | 101% | 100% |
R&D Expenses | €0 | €0 | €0 | €0 | €0 |
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Net Income | €6.8B | €3.8B | €6.8B | €5.5B | €4.1B |
Dep. & Amort. | €789M | €829M | €834M | €711M | €674M |
Def. Tax | -€41M | -€19M | -€31M | -€26M | -€31M |
Stock Comp. | €41M | €19M | €31M | €26M | €0 |
Chg. in WC | €6.6B | €96B | -€22B | -€23B | €3.6B |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | €112B | €108B | €87B | €90B | €70B |
ST Investments | €35B | €30B | €31B | €40B | €45B |
Cash & ST Inv. | €147B | €138B | €119B | €50B | €115B |
Receivables | €1.2B | €1.4B | €1.3B | €834M | €0 |
Inventory | -€164B | -€159B | -€146B | €0 | €0 |
ING achieved a 1% increase in group net selling price (NSP) despite a 1.9% revenue decline, driven by strong cost management and the Bostocks Brothers acquisition, which contributed 2.9 percentage points to New Zealand's volume growth and 2.3 percentage points to overall New Zealand NSP growth.
Core poultry volume declined 2.7% year-on-year, mainly due to a temporary reduction in Australian bird numbers and the transition to a new Woolworths supply agreement, but 75% of lost Woolworths volume has been replaced with new retail and QSR business.
Cost reductions were significant: total costs within EBITDA were $12.4 million lower year-on-year, with internal feed costs down $34 million due to lower input prices and operational efficiencies; cash conversion improved to 94.5%.
FY 2025 guidance was reaffirmed: core poultry volumes expected to decline 1–3% versus normalized FY24, with underlying pre-AASB 16 EBITDA forecast between $236 million and $250 million, and capital expenditure/acquisitions projected at $100–$120 million.
Management expects modest NSP growth and net benefit from lower feed costs in FY25, with ongoing cost savings initiatives; leverage remains within target range (1.8x), and the company is positioned for future growth with a more balanced customer portfolio and strong funding flexibility.